Abstract
A case is presented of a patient with psoriasis in whom squamous cell carcinoma most likely occurred due to the interaction of various factors (psoralen-ultraviolet A therapy, sun exposure, and suppression of natural killer cell function). Therapy consisted of 1 mg/kg/daily of etretinate (Tegison®), which resulted in clearing of psoriatic lesions in one month's time. New carcinomas did not develop and natural killer function improved.
Original language | English |
---|---|
Pages (from-to) | 430-432 |
Number of pages | 3 |
Journal | Cutis |
Volume | 49 |
Issue number | 6 |
Publication status | Published - 1992 |
Field of Science*
- 3.2 Clinical medicine
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database